Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients Caregivers Providers
Log In Ask a Question
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Oncology

Care Team and Survivorship

At a Glance

Living with chronic lymphocytic leukemia (CLL) requires long-term management with a specialized care team. Protecting your immune system from infections, staying up-to-date on safe non-live vaccines, and proactively managing mental health and fatigue are crucial for long-term survivorship.

Living with CLL means managing a chronic condition rather than a short-term illness. Because the disease is complex and the treatment options are changing rapidly, building the right care team and understanding how to protect your health over the long term is essential [1][2].

The Value of a CLL Specialist

Most oncologists treat many types of cancer, but CLL has become so specialized that seeing a CLL-specific specialist (a hematologist-oncologist who focuses primarily on leukemias) can make a significant difference [3][2].

A specialist is often better equipped to:

  • Sequence Therapies: Decide which drug to use first and which to save for later to ensure you have options for decades [1][4].
  • Manage Specific Side Effects: Experts are more familiar with managing the unique heart or bleeding risks of newer targeted pills [2][4].
  • Interpret Complex Markers: They can better explain how your specific DNA markers (like IGHV or TP53) should influence your care [5].

Protecting Your Immune System

Because CLL is a cancer of your immune system’s B-cells, your body may not produce enough healthy antibodies to fight off germs [6][7]. This leads to an increased risk of infections, which is the leading cause of complications in CLL patients [6][8].

  • Hypogammaglobulinemia: This is a common condition in CLL where your levels of Immunoglobulin G (IgG)—a key antibody—are too low [6].
  • IVIG Therapy: If you have low IgG levels and suffer from frequent, severe infections, your doctor may recommend Intravenous Immunoglobulin (IVIG). This is a monthly infusion of healthy antibodies collected from donors [3][9].

Navigating Respiratory Viruses: Viruses like COVID-19, RSV, and the Flu pose significant risks to CLL patients.

  • Vaccines: Staying up-to-date on vaccines is critical. Doctors strongly recommend the COVID-19, RSV, Flu, Shingrix (shingles), and Pneumococcal vaccines [10]. Crucially, CLL patients should generally avoid “live” vaccines (like the nasal flu spray or yellow fever vaccine) [11].
  • Rapid Antivirals: Because your body may not respond fully to vaccines, it is vital to have a plan in place. If you test positive for COVID-19 or the Flu, contact your care team immediately to request rapid access to antiviral medications (like Paxlovid or Tamiflu) before severe symptoms begin.

Navigating the Psychological Toll

Living with an incurable but treatable cancer creates a unique mental burden. Many patients experience Scanxiety—the intense anxiety that builds up before a scheduled blood test or doctor’s visit [12].

  • Chronic Fatigue: Fatigue is one of the most common and frustrating symptoms of CLL. It isn’t just “being tired”; it is a profound exhaustion that can impact your social life and ability to work [13][14]. Do not hesitate to discuss workplace accommodations or disability options with your social worker if the fatigue makes full-time work unsustainable.
  • Watch and Wait Stress: For many, the “watch and wait” period is the most difficult time. It can feel like you are sitting on a “ticking time bomb,” leading to higher levels of distress than those who are actually receiving treatment [12][15].

Survivorship as a Lifestyle

Managing CLL is about more than just the cancer; it is about protecting your overall quality of life. This includes:

  1. Skin Checks: CLL patients have a higher risk of skin cancers. You should see a dermatologist for a full-body check at least once a year.
  2. Exercise and Diet: Staying physically active has been shown to help manage the fatigue and psychological stress of the disease [16].
  3. Mental Health Support: Talk to others who understand the “watch and worry” lifestyle. It can be incredibly validating [12].

Your care team should include not just an oncologist, but also a primary care doctor, a dermatologist, and perhaps a counselor—all working together to keep you healthy for the long journey ahead. [17]

Common questions in this guide

Why do I need a CLL-specific specialist instead of a general oncologist?
A CLL specialist is highly experienced in sequencing rapidly changing therapies and managing specific side effects of newer targeted pills. They can also better interpret your unique DNA markers to tailor a long-term care plan.
Why do CLL patients get sick more often?
CLL is a cancer of the immune system's B-cells, which means your body may not produce enough healthy antibodies to fight off germs. This condition, often marked by low IgG levels, significantly increases your risk for viral and bacterial infections.
What is IVIG therapy for CLL?
Intravenous Immunoglobulin (IVIG) is a monthly infusion of healthy antibodies collected from donors. Your doctor may recommend it if you have low antibody levels and experience frequent or severe infections.
Are vaccines safe for people with CLL?
Most standard vaccines, like those for COVID-19, flu, and shingles, are strongly recommended to protect your weakened immune system. However, CLL patients should generally avoid "live" vaccines, such as the nasal flu spray or yellow fever vaccine.
How can I manage the stress of the watch and wait period?
The watch and wait period can cause intense anxiety, often referred to as scanxiety. Connecting with a mental health counselor, joining a support group, and maintaining regular physical exercise can help manage this unique psychological toll.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.How many patients with CLL do you currently treat, and how do you stay current with the rapidly changing NCCN guidelines?
  2. 2.What is my current IgG (immunoglobulin) level, and at what point would you recommend IVIG therapy for me?
  3. 3.Which vaccines are safe for me right now, and which ones should I specifically avoid?
  4. 4.If I test positive for COVID, RSV, or the Flu, what is the exact protocol to get rapid antivirals?
  5. 5.If my CLL becomes resistant to the first line of treatment, what is your plan for 'sequencing' the next therapies?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (17)
  1. 1

    Recommendations for ibrutinib treatment in patients with atrial fibrillation and/or elevated cardiovascular risk.

    Stühlinger MC, Weltermann A, Staber P, et al.

    Wiener klinische Wochenschrift 2020; (132(3-4)):97-109 doi:10.1007/s00508-019-1534-1.

    PMID: 31414181
  2. 2

    Use of BTK Inhibitors in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): A Practical Guidance.

    St-Pierre F, Ma S

    Blood and lymphatic cancer : targets and therapy 2022; (12()):81-98 doi:10.2147/BLCTT.S326627.

    PMID: 35911566
  3. 3

    Chronic lymphocytic leukaemia.

    Hallek M, Shanafelt TD, Eichhorst B

    Lancet (London, England) 2018; (391(10129)):1524-1537 doi:10.1016/S0140-6736(18)30422-7.

    PMID: 29477250
  4. 4

    Pirtobrutinib after a Covalent BTK Inhibitor in Chronic Lymphocytic Leukemia.

    Mato AR, Woyach JA, Brown JR, et al.

    The New England journal of medicine 2023; (389(1)):33-44 doi:10.1056/NEJMoa2300696.

    PMID: 37407001
  5. 5

    NCCN Guidelines Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 1.2017.

    Wierda WG, Zelenetz AD, Gordon LI, et al.

    Journal of the National Comprehensive Cancer Network : JNCCN 2017; (15(3)):293-311 doi:10.6004/jnccn.2017.0030.

    PMID: 28275031
  6. 6

    Impact of Immune Parameters and Immune Dysfunctions on the Prognosis of Patients with Chronic Lymphocytic Leukemia.

    Vitale C, Boccellato E, Comba L, et al.

    Cancers 2021; (13(15)) doi:10.3390/cancers13153856.

    PMID: 34359757
  7. 7

    The tumor microenvironment in leukemia: molecular pathways of immune evasion.

    Zhu Y, Liu J, Qiu F, et al.

    Frontiers in immunology 2026; (17()):1743920 doi:10.3389/fimmu.2026.1743920.

    PMID: 41727472
  8. 8

    Immune Response Dysfunction in Chronic Lymphocytic Leukemia: Dissecting Molecular Mechanisms and Microenvironmental Conditions.

    Arruga F, Gyau BB, Iannello A, et al.

    International journal of molecular sciences 2020; (21(5)) doi:10.3390/ijms21051825.

    PMID: 32155826
  9. 9

    Chronic Lymphocytic Leukemia: Diagnosis and Treatment.

    Strati P, Jain N, O'Brien S

    Mayo Clinic proceedings 2018; (93(5)):651-664 doi:10.1016/j.mayocp.2018.03.002.

    PMID: 29728204
  10. 10

    Cellular and humoral immune response to mRNA COVID-19 vaccination in subjects with chronic lymphocytic leukemia.

    Lyski ZL, Kim MS, Xthona Lee D, et al.

    Blood advances 2022; (6(4)):1207-1211 doi:10.1182/bloodadvances.2021006633.

    PMID: 34872103
  11. 11

    Reasons and consequences of COVID-19 vaccine failure in patients with chronic lymphocytic leukemia.

    Morawska M

    European journal of haematology 2022; (108(2)):91-98 doi:10.1111/ejh.13722.

    PMID: 34717004
  12. 12

    Patient perspectives of 'Watch and Wait' for chronic haematological cancers: Findings from a qualitative study.

    McCaughan D, Roman E, Sheridan R, et al.

    European journal of oncology nursing : the official journal of European Oncology Nursing Society 2023; (65()):102349 doi:10.1016/j.ejon.2023.102349.

    PMID: 37331194
  13. 13

    Development of a Conceptual Model of Chronic Lymphocytic Leukemia to Better Understand the Patient Experience.

    Eek D, Blowfield M, Krogh C, et al.

    The patient 2021; (14(1)):75-87 doi:10.1007/s40271-020-00440-9.

    PMID: 32808103
  14. 14

    Health state utility and quality of life measures in patients with chronic myeloid leukemia in France.

    S F, P CM, A GB, et al.

    Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2021; (30(7)):2021-2032 doi:10.1007/s11136-021-02794-5.

    PMID: 33651280
  15. 15

    Worsening Quality of Life in Indolent Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia Patients in Active Surveillance: A 12-Month Longitudinal Study.

    Trevino KM, Martin P, Chen Z, Leonard JP

    Clinical lymphoma, myeloma & leukemia 2022; (22(2)):82-88 doi:10.1016/j.clml.2021.08.001.

    PMID: 34479847
  16. 16

    Effects of a strength physical exercise program in chronic lymphocytic leukemia patients on quality of life, mental health, and frailty: a randomized controlled trial study protocol.

    Sánchez-González JL, Fernández-Rodríguez EJ, Méndez-Sánchez R, et al.

    Frontiers in sports and active living 2025; (7()):1534861 doi:10.3389/fspor.2025.1534861.

    PMID: 40129522
  17. 17

    Chronic Lymphocytic Leukemia Care and Beyond: Navigating the Needs of Long-Term Survivors.

    Molica S, Allsup D

    Cancers 2025; (17(1)) doi:10.3390/cancers17010119.

    PMID: 39796746

This page provides educational information about managing life with CLL. Always consult your hematologist-oncologist for specific medical advice, vaccination guidelines, and personalized treatment protocols.

Get notified when new evidence is published on B-cell chronic lymphocytic leukemia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.